The 2023 OncoAlert Colloquium (GU Oncology)
DAY 1 (GU Oncology)February 5, 2024 Start 6pm CET 12 noon EST6pm-6:20 (CET)12 noon-12:20 (EST)Gilberto Morgan (20 min) FDA Approvals in Oncology, OncoAlert …
DAY 1 (GU Oncology)February 5, 2024 Start 6pm CET 12 noon EST6pm-6:20 (CET)12 noon-12:20 (EST)Gilberto Morgan (20 min) FDA Approvals in Oncology, OncoAlert …
Mark D. Tyson, II, MD, MPH, discusses findings from the phase 3 BOND-003 trial in BCG-unresponsive non–muscle-invasive bladder cancer with CIS.
Dana-Farber’s Lynch Syndrome Center’s 9th annual conference for Lynch syndrome patients and families. This year, we celebrated 5 years of the Lynch Syndrome …
Farouc A. Jaffer, MD and M. Chadi Alraies, MD on State of the Art Review and Data on Intravascular Imaging for Coronary Intervention | SIF…
Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.
Myelofibrosis (MF) is a hematologic malignancy that causes progressive bone marrow fibrosis and presents with other clinical manifestations, including anemia…
Stacey Stein, MD, discusses the background and outcomes of the IMbrave150 trial of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma.
Volume 167, issue 2 articles listing for Journal of Neuro-Oncology
JCO Oncology Advances (JCO OA) is a fully open-access, online-only, and interdisciplinary journal committed to accelerating progress in the global fight against cancer. By providing…
Researchers investigated whether listening to mindfulness audio recordings may alleviate the side effects of radiation therapy in men with prostate cancer.
AICR provides the 10 Cancer Prevention Recommendations as a blueprint to help people reduce their cancer risk.